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Abstract 
 
 
 
 
 
 
 
The placenta is an essential organ for embryonic and fetal development, 
ensuring nutrient uptake, gas exchange (via the mother's blood supply), waste 
elimination, thermo-regulation, immunological and hormonal factors, etc. The most 
common placental abnormalities are represented by placenta previa, and a morbidly 
adherent placenta (in the form of accreta, increta, and percreta placenta). 
This study was performed on a sample of 99 patients diagnosed with 
abnormalities of placentation who underwent cesarian delivery during a period of 3 
years in Bucur Maternity Hospital. Seven patients were diagnosed with morbidly 
adherent placenta (5 accreta and 2 percreta subtypes), the others having placenta 
previa (65 with lateral disposition, 18 marginal, and 9 central insertion). All patients 
had been diagnosed by ultrasound (which was also used for general monitoring), 
being confirmed during operation and histopathologically. Complications required 4 
emergency peripartum hysterectomies, with no maternal mortality but with fetal 
death in one case. 
The research literature shows that about half of women with placenta previa 
have several episodes of bleeding, being the leading cause of antepartum 
hemorrhage. For some women with placenta previa/accrete, hemorrhaging is severe 
and requires hysterectomy as a necessary step to control the life-threatening 
situation. Thus, such patients should be carefully monitored to avoid as much as 
possible the medical, social, and psychological implications of this critical 
therapeutic procedure. 
 
 
Acne conglobata is a rare, severe form of acne vulgaris characterized by the presence of comedones, 
papules, pustules, nodules and sometimes hematic or meliceric crusts, located on the face, trunk, neck, arms 
and buttocks.  
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Introduction 
The placenta first develops during the blastocyst 
stage and is expulsed with the fetus at birth. The fetus 
uses the placenta for nutrition and other developmentally 
essential functions. Therefore, abnormalities (expansion 
or the site of implantation, structure or placental 
function, and finally inadequate disposition of the 
placental cord) may jeopardize embryonic and fetal 
development. The most frequently encountered 
abnormalities are represented by placenta previa and 
morbidly adherent placenta/ (MAP) (in the form of 
accreta, increta and percreta placenta), being classified 
by the depth of penetration of the placental villi into the 
myometrium. 
Placenta previa, a condition when the placenta 
overlies the internal cervical os of the uterus, occurs in 
approximately 1/ 250 pregnancies. It has major risk 
factors such as prior cesarean delivery, pregnancy 
termination, intrauterine surgery, and increasing parity 
(1). Placenta previa reappears in women with multiple 
parturitions at a relatively high frequency, representing 
about 4-8% for their most recent pregnancies (2). In 
addition, a short interval between gestations is associated 
with increased risks of previa and abruption (3). A North 
American study revealed a 47% increased risk of 
placenta previa after the first cesarian-section (C-
section), and a 40% increased risk of placental abruption 
in the second pregnancy with a singleton (4). 
The incidence of placenta accreta has increased by a 
factor of 13 since the early 1900s, and it is directly 
correlated with the increasing cesarean birth rate (5). 
Moreover, the incidence of placenta accreta significantly 
increases in women with previous cesarean section, 
compared with those without a prior surgical pregnancy 
(6, 7). Further study has revealed that the incidence of 
placenta accreta has increased from 0.12% during the 
1970s, to 0.31% during the 2000s. During the same 
period, cesarean section rates increased from 17% to 
64%, making it the most significant predisposing 
condition for placenta accreta (8). 
Recent investigations have proposed to establish a 
measurement plan able to quantify the frequency of 
elective cesarean section, along with relevant 
geographical, social, and economic information. The 
results have shown that in 2014, the rate reached 36.9 
cases for every 100 newborn infants, 2.62% higher than 
in 2013 (9).  
Other health issues are relevant to placental function. 
For example, the relationship between gestational age 
and volume of the placenta has been associated with 
increased risk of cardiovascular disease death in the 
mother or the children, therefore suggesting that 
placental function is an important factor regarding the 
cardiovascular disease at older ages (10, 11).  
Furthermore, any changes in placental structure and 
function might significantly increase the risk of stillbirth. 
Therefore, an important goal towards understanding 
placental dysfunction is to develop improved procedures 
for pregnancy monitoring (12). 
Vaginal bleeding encountered after 20 or more 
weeks of gestation should raise the suspicion of placenta 
previa. However, all pregnant women with vaginal 
bleeding and cytologic suspicion of cervical cancer 
(excepting squamous atypia or low-grade squamous 
intraepithelial lesions) should undergo colposcopy, with 
or without biopsy (13). 
 
Materials and methods  
The study used 99 patients, ages 21 to 42 years, 
diagnosed with abnormalities of placentation and 
undergoing cesarean delivery in Bucur Maternity 
Hospital during a 3 year period from 2014 to 2017. Two 
additional groups consisting of 92 patients with placenta 
previa and 7 patients with morbidly adherent placenta 
were also studied. Gestational age was between 28 and 
41 weeks, with 8 premature deliveries. 
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Twelve patients had a medical history of having 
undergone a C-section, and 28 patients had had two or 
more deliveries. All patients were diagnosed by 
ultrasound and monitored during their entire gestational 
period until delivery. 
Relationships were established between mortality, 
morbidity, days in ICU (intensive care unit), blood 
transfusion units, obstetrical history and the type of 
placental abnormality. The majority of the patients were 
aged 25 to 35, 55% of them belonging to 25-35 years old 
interval (Figure 1). 
 
Figure 1. Distribution according to age intervals 
Despite being primiparous, 71 patients developed 
the same abnormalities of placentation as patients having 
risk factors.Overall, from 92 patients with placenta 
previa, 65 had lateral disposition, 18 marginal, and 9 
placenta central situation. Seven patients developed 
MAP, with 5 accreta, and 2 percreta variations (Figure 2). 
 
Figure 2. Variations of placentation abnormalities 
Complications were related to both fetal and 
maternal counterparts, with 4 emergency peripartum 
hysterectomies (EPH), one fetal death, and no maternal 
mortality. 
No admissions to ICU for non-complicated C-
sections were registered, but 2-3 days of ICU were 
registered for EPH cases. Blood transfusion was 
necessary only for anemia under 7mg/dl, for a selected 
group of patients with haemophilia (5 patients), and 
emergency peripartum hysterectomy (4 patients). 
 
Results and Discussion 
Early detection of abnormalities of placentation is 
very important for a healthy pregnancy, as it allows 
appropriate surgical management when necessary. The 
diagnosis is made mainly using imagistic methods such 
as ultrasonography and magnetic resonance imaging 
(MRI). 
Ultrasound 
As a reliable method of diagnostic and imagistic 
follow-up, ultrasound has high sensitivity and specificity 
for detecting placental abnormalities, being the primary 
screening technique with a well-established reputation 
for safety and accuracy. It is useful for a differential 
diagnosis between placental abnormalities and uterine 
adhesions, septate uterus, circumvallate placenta, 
amniotic band or amniotic sheet (14). Early diagnostic 
signs include the absence of a retroplacental clear zone 
and the presence of placental lacunae. Ultrasound can 
also reveal the presence of nuchal cord in the third 
trimester which should obviate the need for cesarean 
section delivery, given that data show a lack of 
association between its presence and poor neonatal 
outcome (15). Also, in the target group of women with a 
potential to develop abnormal placental structure, 
ultrasound scan at 19-23 weeks preceded 15 out of 22 
stillbirths (16). Overall, this investigative procedure 
assists with planning the mode of delivery (17). 
In our study ultrasound revealed (from 99 patients) 
92 subjects with placenta previa, 65 having lateral 
disposition, 18 marginal and 9 central placenta 
disposition. 7 patients developed MAP, with 5 accreta, 
and 2 percreta variations. All ultrasound determinations 
were consistent with both intraoperator and 
histopathological findings. 
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Magnetic resonance imaging (MRI) 
Both ultrasound and MRI can describe abnormal 
placentation (with specific limitations for each method), 
the latter being considered when ultrasound results are 
inconclusive (18) even though MRI is more expensive 
and has limited availability. MRI is most useful for the 
diagnosis of complicated placenta previa (such as 
previa/accreta and previa/percreta), placental and 
cervical tissues presenting specific/ different 
characteristics to magnetic resonance (19). 
In our study all patients have been early diagnosed 
by ultrasound, and monitored during gestation for any 
modification that could lead to unexpected surgical 
interventions. 
Complications 
Major obstetric hemorrhage is the primary cause for 
maternal morbidity and mortality. An important risk 
factor for abnormal placental adherence is placenta 
previa in the presence of a uterine scar. Also, uterine 
scarring may lead to abnormal trophoblast invasion, 
and/or to association of cesarean section with placenta 
accreta and scar pregnancies (20).  
Maternal morbidity from placenta previa is primarily 
related to antepartum and/or postpartum hemorrhage, 
blood transfusions, and subsequent emergency 
peripartum hysterectomy (EPH) (Figure 3, a-b). On a 
sample of 13.162 patients who underwent cesarean or 
vaginal delivery in Bucur Maternity Hospital over 6 
years (from 2010 to 2015), 12 cases were encountered in 
which one or more of the risk factors that lead to EPH 
were found (21). 
In the current study, complications were related to 
both fetal and maternal counterparts, with 4 EPH, one 
fetal death, and no maternal mortality. Three of four 
EPH were performed for percreta situations and led to 
75% morbidity in those cases. We found no usual ICU 
admission, excepting the C-sections complicated with 
EPH, when a 2-3 days period of intensive care was 
necessary for adequate monitoring. Depending on the 
hemoglobin value, patients with values between 7 and 
9mg/dl were administered ferrous supplements to correct 
anemia. For all patients with values below 7mg/dl, blood 
transfusion (1-2 U.I.) was performed. Only one fetal 
death was registered due to an extreme prematurity 
associated the Down syndrome. 
 
Figure 3. The hysterectomy piece for placenta accreta 
(A); The ultrasound before the intervention (B) 
General Discussion and Conclusions 
Placenta percreta significantly increases the risk for 
both maternal and fetal morbidity and mortality, and 
invasion of the bladder carries a maternal morbidity of 
9.5% and perinatal mortality of 24% (22). 
Recommendations of The American College of 
Obstetricians and Gynecologists for the management of 
suspected placenta accreta include aplanned preterm 
cesarean section, with the placenta left in situ because its 
removal is associated with significant hemorrhagic 
morbidity. However, surgical management of placenta 
accreta may be individualized (23, 24). In systematic 
reviews, 52 percent of women with placenta previa had 
antepartum bleeding, and 22 percent had postpartum 
hemorrhage. The risks of hemorrhage and postpartum 
hysterectomy are particularly high for women with 
previa/accreta placenta (25-27). 
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Following C-section, there is a 0.3% increased risk 
of a major adverse maternal event during the next 
pregnancy. In each subsequent pregnancy, the 
cumulative risk of a major adverse maternal event 
increases, reaching up to 10% by the fourth C-section 
delivery (28). Another complication is premature birth, 
reported for 15% of patients with placenta previa 
delivered before 34 weeks of gestation (29).  
Finally, in stillbirth cases, levels of plasma protein A 
(PAPP-A) in the lowest 5% and alpha fetoprotein (AFP) 
in the highest 5% are associated with increased the risk 
of stillbirth by 50-fold and 2.8-fold respectively (30). 
 
 
Conclusions 
Any vaginal bleeding encountered at 20 or more 
weeks of gestation in women should raise the suspicion 
of placenta previa.In addition, the presence of uterine 
scar tissue (indicating previous C-section) should alert 
the physician to the possibility of a placenta previaor 
accreta/increta/percreta developing during gestation. 
Arigorous screening test for all such abnormalities of 
placentation is necessary, especially when ultrasound 
aspectspersist into the third trimester (and extend over 
the cervical os by ≥25 mm).Previous cesarean deliveries 
and increased parity, along with previousabortionsand 
uterine surgical procedures,are major risk factors for 
placenta previa. 
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